Section Arrow
ALMR.NASDAQ
- Alamar Biosciences Inc
Quotes are at least 15-min delayed:2026/11/20 17:26 EST
After Hours
Last
 26.48
0 (0.00%)
Bid
26.2
Ask
27.5
High 26.5 
Low 26.48 
Volume 5.87K 
Regular Hours (Closed)
Last
 26.48
-2.2 (-7.67%)
Day High 
28.25 
Prev. Close
28.68 
1-M High
35.33 
Volume 
712.58K 
Bid
26.2
Ask
27.5
Day Low
26.24 
Open
28.25 
1-M Low
25.31 
Market Cap 
1.99B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 30.6 
20-SMA 30.57 
50-SMA 30.31 
52-W High 39.61 
52-W Low 18.845 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.79/-0.48
Enterprise Value
2.03B
Balance Sheet
Book Value Per Share
4.37
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
74.21M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 41.9407 -0.0393 -0.09%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.61 -0.02 -1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.89 -0.05 -0.05%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.9699 +0.0609 +6.70%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103 0 0.00%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.